Clover Health Investments, Corp.
NASDAQ:CLOV
3.66 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 336.963 | 330.986 | 356.26 | 346.922 | 510.251 | 306.028 | 320.138 | 321.992 | 898.791 | 856.817 | 846.7 | 874.379 | 432.036 | 427.163 | 412.472 | 200.325 | -506.655 | 169.069 | 172.081 | 165.505 | 0 | 118.384 | 117.905 | 117.905 |
| Cost of Revenue
| 243.044 | 249.774 | 248.347 | 265.162 | 447.985 | 235.785 | 244.262 | 274.789 | 893.645 | 839.799 | 858.786 | 861.722 | 441.803 | 436.325 | 458.503 | 214.42 | 0 | 144.846 | 119.366 | 146.328 | 0 | 0 | 0 | 0 |
| Gross Profit
| 93.919 | 81.212 | 107.913 | 81.76 | 62.266 | 70.243 | 75.876 | 47.203 | 5.146 | 17.018 | -12.086 | 12.657 | -9.767 | -9.162 | -46.031 | -14.095 | 0 | 24.223 | 52.715 | 19.177 | 0 | 118.384 | 117.905 | 117.905 |
| Gross Profit Ratio
| 0.279 | 0.245 | 0.303 | 0.236 | 0.122 | 0.23 | 0.237 | 0.147 | 0.006 | 0.02 | -0.014 | 0.014 | -0.023 | -0.021 | -0.112 | -0.07 | 0 | 0.143 | 0.306 | 0.116 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 115.023 | 90.196 | 99.923 | 103.792 | 109.929 | 101.597 | 104.147 | 126.625 | 124.349 | 117.974 | 117.531 | 126.788 | 114.207 | 119.21 | 107.813 | 104.642 | 0 | 46.475 | 40.695 | 49.967 | 0 | 19.69 | 22.953 | 22.953 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.171 | 26.349 | 26.349 |
| SG&A
| 115.023 | 90.196 | 99.923 | 103.792 | 109.929 | 101.597 | 104.147 | 126.625 | 124.349 | 117.974 | 117.531 | 126.788 | 114.207 | 119.21 | 107.813 | 104.642 | 0 | 46.475 | 40.695 | 49.967 | 0 | 36.861 | 49.302 | 49.302 |
| Other Expenses
| 0.344 | -0.199 | 0.803 | 0.671 | 17.997 | 2.262 | 0.611 | 0.276 | -12.04 | -26.86 | -26.89 | -26.65 | 62.815 | 20.881 | 28.018 | 0.351 | -524.871 | -0.634 | -11.15 | -4.16 | 0.018 | 0 | 0 | 0 |
| Operating Expenses
| 115.367 | 89.997 | 100.726 | 104.463 | 127.926 | 103.859 | 104.758 | 126.901 | 112.309 | 91.114 | 90.641 | 100.138 | 177.022 | 140.091 | 135.831 | 104.993 | -524.871 | 45.841 | 29.545 | 45.807 | 0.018 | 162.568 | 230.527 | 230.527 |
| Operating Income
| -21.448 | -8.785 | 7.187 | -22.703 | -65.66 | -33.616 | -28.882 | -79.698 | -107.163 | -74.096 | -102.727 | -87.481 | -186.789 | -149.253 | -181.862 | -119.088 | 18.216 | -21.618 | 23.17 | -26.63 | -0.018 | -30.853 | -44.286 | -44.286 |
| Operating Income Ratio
| -0.064 | -0.027 | 0.02 | -0.066 | -0.13 | -0.086 | -0.056 | -0.138 | -0.119 | -0.086 | -0.121 | -0.1 | -0.432 | -0.349 | -0.441 | -0.594 | -0.407 | -0.128 | 0.135 | -0.161 | -0 | -0.261 | -0.376 | -0.376 |
| Total Other Income Expenses Net
| -0.033 | 0 | -0.017 | -0.467 | -4.812 | 0 | -0.007 | 0 | 23.117 | -1.393 | -1.635 | 11.991 | -0.412 | 114.726 | -135.749 | 70.671 | -14.96 | 34.376 | -17.767 | -1.532 | 0 | -20.811 | -72.415 | -72.415 |
| Income Before Tax
| -21.481 | -8.785 | 7.17 | -23.17 | -70.472 | -33.616 | -28.889 | -79.698 | -84.046 | -75.489 | -104.362 | -75.49 | -187.201 | -34.527 | -317.611 | -48.417 | 3.256 | 12.758 | 5.403 | -28.162 | -0.018 | -51.664 | -116.701 | -116.701 |
| Income Before Tax Ratio
| -0.066 | -0.028 | 0.02 | -0.067 | -0.139 | -0.086 | -0.056 | -0.138 | -0.094 | -0.088 | -0.123 | -0.086 | -0.433 | -0.081 | -0.77 | -0.242 | -0.491 | 0.075 | 0.031 | -0.17 | -0 | -0.436 | -0.99 | -0.99 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20.811 | -72.415 | -72.415 |
| Net Income
| -22.092 | -9.155 | 7.408 | -19.17 | -70.472 | -41.469 | -28.814 | -72.606 | -84.046 | -75.489 | -104.362 | -75.49 | -187.201 | -34.527 | -317.611 | -48.417 | 3.256 | 12.758 | 5.403 | -28.162 | -0.018 | -51.664 | -116.701 | -116.701 |
| Net Income Ratio
| -0.066 | -0.028 | 0.021 | -0.055 | -0.139 | -0.086 | -0.056 | -0.138 | -0.069 | -0.089 | -0.123 | -0.072 | -0.433 | -0.081 | -0.77 | -0.242 | -0.491 | 0.075 | 0.031 | -0.17 | -0 | -0.436 | -0.99 | -0.99 |
| EPS
| -0.045 | -0.02 | 0.01 | -0.04 | -0.15 | -0.09 | -0.06 | -0.16 | -0.18 | -0.16 | -0.22 | -0.16 | -0.4 | -0.082 | -0.78 | -0.13 | -0.2 | 0.032 | 0.005 | -0.07 | 0 | -1.21 | -2.76 | -2.76 |
| EPS Diluted
| -0.045 | -0.02 | 0.01 | -0.04 | -0.15 | -0.09 | -0.06 | -0.16 | -0.18 | -0.16 | -0.22 | -0.16 | -0.4 | -0.082 | -0.78 | -0.13 | -0.2 | 0.032 | 0.005 | -0.07 | 0 | -1.21 | -2.76 | -2.76 |
| EBITDA
| -21.137 | -8.446 | 7.5 | -22.032 | -69.798 | -33.059 | -27.883 | -77.612 | -84.748 | -74.46 | -103.368 | -74.261 | -185.941 | -33.981 | -316.256 | -33.422 | -37.356 | 26.572 | 18.848 | -14.513 | -0.018 | -20.811 | -72.415 | -72.415 |
| EBITDA Ratio
| -0.063 | -0.026 | 0.022 | -0.061 | -0.093 | -0.082 | -0.045 | -0.137 | -0.119 | -0.086 | -0.121 | -0.099 | -0.43 | -0.349 | -0.441 | -0.594 | -0.406 | -0.127 | 0.136 | -0.16 | -0 | -0.176 | -0.614 | -0.614 |